| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-10 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.25 | 8e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.12 | 1e-05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |